TCR-T

BIOLOGICAL2 trials

Sponsors

Lion TCR Pte. Ltd., Beijing 302 Hospital

Conditions

Chronic Hepatitis BHepatocellular Carcinoma

Phase 1

A Study of TCR-Redirected T Cell Infusion to Prevent Hepatocellular Carcinoma Recurrence Post Liver Transplantation

CompletedNCT02686372

Lion TCR Pte. Ltd.Hepatocellular Carcinoma

Start: 2018-05-16End: 2021-09-28Updated: 2022-06-30

Autologous T-cells Transfected With mRNA Encoding HBV-TCR T Cell Therapy in Combination With NUC for Chronic Hepatitis B

Active, not recruitingNCT05905731

Beijing 302 HospitalChronic Hepatitis B

Start: 2023-06-01End: 2026-06-30Target: 20Updated: 2023-06-15